Lv3
300 积分 2022-11-17 加入
A Deep Prostate-specific Antigen Response to Darolutamide plus Androgen Deprivation Therapy Is Associated with Better Clinical Outcomes in the Phase 3 ARANOTE Trial in Patients with Metastatic Hormone-sensitive Prostate Cancer
2个月前
已关闭
Oncological and Survival Outcomes of Pelvic Lymph Node Dissection in Patients with Nonmuscle Invasive Bladder Cancer Undergoing Radical Cystectomy Using the National Cancer Database
2个月前
已完结
Life Expectancy of Renal Cell Carcinoma with Variant Histology
2个月前
已完结
Heterogeneity of the Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: A Living Interactive Systematic Review and Meta-analysis
2个月前
已完结
Management Dilemma for Very High-risk Non–muscle-invasive Bladder Cancer: Real-World Data Challenge the Guideline Recommendation for Upfront Radical Cystectomy
2个月前
已完结
Refining the Role of Androgen Deprivation Therapy After Radical Prostatectomy
2个月前
已完结
Key strategies for reducing recurrence in T1 bladder cancer. Evidence from a retrospective multicenter European study
2个月前
已完结
Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis
2个月前
已完结
Comparative Analysis of Outcomes for Patients With Advanced Renal Cell Carcinoma: Immuno-Oncology EraVersusTyrosine Kinase Inhibitor Era in the IMDC Favorable-risk Group
2个月前
已完结
Improving Urothelial Carcinoma Outcomes: The Powerful Combination of Neoadjuvant and Adjuvant Chemotherapy in the Perioperative Period
2个月前
已完结
皖公网安备34019202002308
